ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Pharma R&D links industry, academia

by Michael McCoy
April 25, 2016 | APPEARED IN VOLUME 94, ISSUE 17

[+]Enlarge
Credit: University of Chicago
Researchers at the University of Chicago.
Credit: University of Chicago
Researchers at the University of Chicago.

The University of Chicago and AbbVie are joining to accelerate oncology drug ­discovery. Under the five-year agreement, AbbVie will provide funding to the university that may be used for preclinical research and clinical trials; it gains an option to exclusively license discoveries made under the agreement. Separately, Sanford Burnham Prebys (SBP) Medical Discovery Institute and GlaxoSmithKline have formed the SBP-GSK Center for Translational Neuroscience. Under a three-year agreement, GSK will support a research lab on SBP’s La Jolla, Calif., campus.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment